246 related articles for article (PubMed ID: 18522746)
1. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.
Kresse SH; Skårn M; Ohnstad HO; Namløs HM; Bjerkehagen B; Myklebost O; Meza-Zepeda LA
Mol Cancer; 2008 Jun; 7():48. PubMed ID: 18522746
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours.
Storlazzi CT; Brekke HR; Mandahl N; Brosjö O; Smeland S; Lothe RA; Mertens F
J Pathol; 2006 Aug; 209(4):492-500. PubMed ID: 16721726
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome.
Skotheim RI; Kallioniemi A; Bjerkhagen B; Mertens F; Brekke HR; Monni O; Mousses S; Mandahl N; Soeter G; Nesland JM; Smeland S; Kallioniemi OP; Lothe RA
J Clin Oncol; 2003 Dec; 21(24):4586-91. PubMed ID: 14673046
[TBL] [Abstract][Full Text] [Related]
4. Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection.
Kolberg M; Høland M; Lind GE; Ågesen TH; Skotheim RI; Hall KS; Mandahl N; Smeland S; Mertens F; Davidson B; Lothe RA
Mol Oncol; 2015 Jun; 9(6):1129-39. PubMed ID: 25769404
[TBL] [Abstract][Full Text] [Related]
5. Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease.
Schmidt H; Taubert H; Meye A; Würl P; Bache M; Bartel F; Holzhausen HJ; Hinze R
Cancer Lett; 2000 Jul; 155(2):181-90. PubMed ID: 10822134
[TBL] [Abstract][Full Text] [Related]
6. cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.
Karube K; Nabeshima K; Ishiguro M; Harada M; Iwasaki H
J Clin Pathol; 2006 Feb; 59(2):160-5. PubMed ID: 16443732
[TBL] [Abstract][Full Text] [Related]
7. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.
Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M
Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533
[TBL] [Abstract][Full Text] [Related]
8. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.
Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array.
Mantripragada KK; Díaz de Ståhl T; Patridge C; Menzel U; Andersson R; Chuzhanova N; Kluwe L; Guha A; Mautner V; Dumanski JP; Upadhyaya M
Genes Chromosomes Cancer; 2009 Oct; 48(10):897-907. PubMed ID: 19603524
[TBL] [Abstract][Full Text] [Related]
10. Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor.
Yu J; Deshmukh H; Payton JE; Dunham C; Scheithauer BW; Tihan T; Prayson RA; Guha A; Bridge JA; Ferner RE; Lindberg GM; Gutmann RJ; Emnett RJ; Salavaggione L; Gutmann DH; Nagarajan R; Watson MA; Perry A
Clin Cancer Res; 2011 Apr; 17(7):1924-34. PubMed ID: 21325289
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization.
Nakagawa Y; Yoshida A; Numoto K; Kunisada T; Wai D; Ohata N; Takeda K; Kawai A; Ozaki T
Oncol Rep; 2006 Feb; 15(2):297-303. PubMed ID: 16391845
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
13. Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group.
Brekke HR; Ribeiro FR; Kolberg M; Agesen TH; Lind GE; Eknaes M; Hall KS; Bjerkehagen B; van den Berg E; Teixeira MR; Mandahl N; Smeland S; Mertens F; Skotheim RI; Lothe RA
J Clin Oncol; 2010 Mar; 28(9):1573-82. PubMed ID: 20159821
[TBL] [Abstract][Full Text] [Related]
14. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).
Alaggio R; Turrini R; Boldrin D; Merlo A; Gambini C; Ferrari A; Dall'igna P; Coffin CM; Martines A; Bonaldi L; De Salvo GL; Zanovello P; Rosato A
PLoS One; 2013; 8(11):e80456. PubMed ID: 24303016
[TBL] [Abstract][Full Text] [Related]
15. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
[TBL] [Abstract][Full Text] [Related]
16. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization.
Mechtersheimer G; Otaño-Joos M; Ohl S; Benner A; Lehnert T; Willeke F; Möller P; Otto HF; Lichter P; Joos S
Genes Chromosomes Cancer; 1999 Aug; 25(4):362-9. PubMed ID: 10398430
[TBL] [Abstract][Full Text] [Related]
17. Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant.
Schmidt H; Würl P; Taubert H; Meye A; Bache M; Holzhausen HJ; Hinze R
Genes Chromosomes Cancer; 1999 Jul; 25(3):205-11. PubMed ID: 10379866
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
Subramanian S; Thayanithy V; West RB; Lee CH; Beck AH; Zhu S; Downs-Kelly E; Montgomery K; Goldblum JR; Hogendoorn PC; Corless CL; Oliveira AM; Dry SM; Nielsen TO; Rubin BP; Fletcher JA; Fletcher CD; van de Rijn M
J Pathol; 2010 Jan; 220(1):58-70. PubMed ID: 19890883
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization.
Romero A; Martín M; Cheang MC; López García-Asenjo JA; Oliva B; He X; de la Hoya M; García Sáenz JÁ; Arroyo Fernández M; Díaz Rubio E; Perou CM; Caldés Llopis T
Am J Pathol; 2011 Apr; 178(4):1453-60. PubMed ID: 21435434
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.
Sønderstrup IM; Nygård SB; Poulsen TS; Linnemann D; Stenvang J; Nielsen HJ; Bartek J; Brünner N; Nørgaard P; Riis L
Mol Oncol; 2015 Jun; 9(6):1207-17. PubMed ID: 25777966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]